Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Total Current Liabilities (2013 - 2026)

Scienture Holdings' (SCNX) quarterly Total Current Liabilities came in at $3.0 million in Q2 2026, down 60.64% year-over-year from $7.7 million in Q2 2025, and up 7.94% quarter-over-quarter from $2.8 million in Q1 2026.

Analysis

Scienture Holdings (SCNX) Total Current Liabilities (2013 - 2026) Analysis & Trends

Scienture Holdings has disclosed Total Current Liabilities across 14 years of filings, most recently posting $3.0 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities fell 60.64% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $3.0 million (down 60.64% YoY), while the FY2025 annual figure was $2.7 million, down 65.41% from the prior year.
  • Total Current Liabilities came in at $3.0 million for Q2 2026 at Scienture Holdings, up from $2.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $11.6 million in Q4 2023 to a low of $1.6 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $4.7 million, with a median of $3.0 million recorded in 2024.
  • Year-over-year, Total Current Liabilities surged 438.31% in 2023 and plunged 65.41% in 2025.
  • Over 5 years, Total Current Liabilities stood at $2.1 million in 2022, then surged by 438.31% to $11.6 million in 2023, then slumped by 31.58% to $7.9 million in 2024, then plunged by 65.41% to $2.7 million in 2025, then rose by 10.64% to $3.0 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $3.0 million in Q2 2026, $2.8 million in Q1 2026, and $2.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 15.65 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 6.35 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 1.66 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 883.19 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 4.54 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 283.66 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 331.18 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 263.21 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 12.39 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 3.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.03 Mn
Mar 31, 2026 2.80 Mn
Dec 31, 2025 2.74 Mn
Jun 30, 2025 7.69 Mn
Mar 31, 2025 7.46 Mn
Dec 31, 2024 7.91 Mn
Jun 30, 2024 2.90 Mn
Mar 31, 2024 2.95 Mn
Dec 31, 2023 11.56 Mn
Sep 30, 2023 9.09 Mn
Jun 30, 2023 4.26 Mn
Dec 31, 2022 2.15 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 2.55 Mn
Mar 31, 2022 1.60 Mn
Dec 31, 2021 926,026.00
Sep 30, 2021 654,861.00
Jun 30, 2021 861,051.00
Mar 31, 2021 1.24 Mn
Dec 31, 2020 842,238.00